The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
amylin pharmaceuticals | 758 |
astrazeneca | 226 |
alkermes pharma ireland | 38 |
eli lilly & company | 24 |
aegerion pharmaceuticals | 20 |
alkermes | 20 |
amgen | 5 |
amilin farmas'jutikalz | 4 |
gruppo biomed mod | 3 |
bionebraska | 3 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
hybrid polypeptides with selectable properties | 45 | 2004 |
highly soluble leptins | 43 | 2010 |
amylin and amylin agonists for treating psychiatric diseases and disorders | 37 | 2005 |
polymer-based sustained release device | 33 | 2004 |
exendin for treating diabetes and reducing body weight | 32 | 2005 |
sustained release formulations using non-aqueous carriers | 29 | 2008 |
polymer-based sustained release device | 27 | 2004 |
regulation gastrointestinaler beweglichkeit | 25 | 1996 |
treatment of obesity and related disorders | 24 | 2004 |
pancreatic polypeptide family motifs, polypeptides and methods comprising the same | 20 | 2004 |